Sigachi Industries Limited (SIGACHI.NS)
INR 38.0
(2.43%)
INR 38.0
(2.43%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 265.79 Million INR | 10.42% |
| 2022 | 240.71 Million INR | 1883.27% |
| 2021 | 12.13 Million INR | -35.67% |
| 2020 | 18.86 Million INR | -1.21% |
| 2019 | 19.09 Million INR | 54.77% |
| 2018 | 12.34 Million INR | -62.99% |
| 2017 | 33.34 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 265.79 Million INR | 10.42% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 419.44 Million INR | 0.0% |
| 2023 Q4 | 265.79 Million INR | 0.0% |
| 2022 Q4 | 240.71 Million INR | 0.0% |
| 2022 FY | 240.71 Million INR | 1883.27% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 240.77 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q1 | 18.06 Million INR | -4.24% |
| 2021 Q4 | 12.13 Million INR | 0.0% |
| 2021 FY | 12.13 Million INR | -35.67% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 15.39 Million INR | -14.82% |
| 2020 Q4 | 18.86 Million INR | 0.0% |
| 2020 Q1 | - INR | 0.0% |
| 2020 FY | 18.86 Million INR | -1.21% |
| 2019 FY | 19.09 Million INR | 54.77% |
| 2018 FY | 12.34 Million INR | -62.99% |
| 2017 FY | 33.34 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 628.8 Million INR | 57.729% |
| Hester Biosciences Limited | 1.81 Billion INR | 85.377% |
| Aarti Drugs Limited | 2.75 Billion INR | 90.346% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -66349.5% |
| Albert David Limited | 6.01 Million INR | -4318.185% |
| Alembic Limited | 73.9 Million INR | -259.673% |
| Alkem Laboratories Limited | 400 Million INR | 33.551% |
| Bafna Pharmaceuticals Limited | 107.53 Million INR | -147.18% |
| Bajaj HealthCare Limited | 650.34 Million INR | 59.13% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Brooks Laboratories Limited | 3.56 Million INR | -7355.764% |
| Eris Lifesciences Limited | 6.54 Billion INR | 95.939% |
| FDC Limited | 2.46 Million INR | -10678.508% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -80.068% |
| Gufic Biosciences Limited | 1.53 Billion INR | 82.736% |
| Hikal Limited | 4.22 Billion INR | 93.714% |
| Ind-Swift Limited | 10.09 Billion INR | 97.367% |
| Innova Captab Limited | 2.1 Billion INR | 87.374% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -251.724% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 99.161% |
| Lincoln Pharmaceuticals Limited | - INR | -Infinity% |
| Lupin Limited | 1.55 Billion INR | 82.883% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -99.038% |
| Medico Remedies Limited | 8.67 Million INR | -2965.014% |
| Morepen Laboratories Limited | 33.64 Million INR | -690.125% |
| Nectar Lifesciences Limited | 1.4 Billion INR | 81.056% |
| Orchid Pharma Limited | 1.2 Billion INR | 77.929% |
| Procter & Gamble Health Limited | 68.8 Million INR | -286.334% |
| RPG Life Sciences Limited | -30.3 Million INR | 977.221% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Solara Active Pharma Sciences Limited | 1.17 Billion INR | 77.367% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -25.166% |
| Themis Medicare Limited | 267.74 Million INR | 0.725% |
| Unichem Laboratories Limited | 382.22 Million INR | 30.46% |
| Vaishali Pharma Limited | 35.98 Million INR | -638.677% |
| Wanbury Limited | 820 Million INR | 67.586% |
| Windlas Biotech Limited | 20.18 Million INR | -1217.136% |
| ZIM Laboratories Limited | 356 Million INR | 25.339% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -138.115% |
| Ipca Laboratories Limited | 5.8 Billion INR | 95.421% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -1898.481% |
| Venus Remedies Limited | 386.8 Million INR | 31.283% |
| Sakar Healthcare Limited | 549.55 Million INR | 51.634% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 98.755% |
| Divi's Laboratories Limited | 20 Million INR | -1228.99% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -854.871% |
| Mankind Pharma Limited | 325.81 Million INR | 18.421% |
| Sequent Scientific Limited | 1.42 Billion INR | 81.376% |
| Laurus Labs Limited | 7.98 Billion INR | 96.67% |
| Neuland Laboratories Limited | 449.2 Million INR | 40.829% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -12.436% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | 82.478% |
| Zydus Lifesciences Limited | 251 Million INR | -5.896% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -1802.907% |
| Wockhardt Limited | 8.91 Billion INR | 97.017% |
| Bal Pharma Limited | 363.82 Million INR | 26.943% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | 95.563% |
| Bliss GVS Pharma Limited | 355.92 Million INR | 25.321% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 9.2 Million INR | -2789.109% |
| Shilpa Medicare Limited | 5.6 Billion INR | 95.255% |
| Valiant Laboratories Limited | 750.89 Million INR | 64.603% |
| Ajanta Pharma Limited | 235.2 Million INR | -13.009% |
| Aarey Drugs & Pharmaceuticals Limited | 32.24 Million INR | -724.339% |
| Granules India Limited | 689.71 Million INR | 61.462% |
| Medicamen Biotech Limited | 12.55 Million INR | -2017.069% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 21904.594% |
| Piramal Enterprises Limited | 535.85 Billion INR | 99.95% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 98.343% |
| NATCO Pharma Limited | 53 Million INR | -401.506% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | 85.515% |
| Strides Pharma Science Limited | 6.71 Billion INR | 96.042% |
| Indoco Remedies Limited | 3.51 Billion INR | 92.443% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -149.341% |